Delivery Order SPE2DB22D1106-SPE2DB25FFAH9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cervidil 10 mg vaginal inserts, with a ceiling value of $5,415.04 under a firm fixed-price contract type. The contract carries an ultimate completion date of July 21, 2025, and represents a non-set-aside, competitively awarded delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,384.40 to AmerisourceBergen Drug Corp for the supply of Cervidil 10 mg vaginal inserts. This is a firm fixed-price, competitive award with no set-aside designation, issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $3,384.40 delivery order to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, with an ultimate completion date of July 31, 2025. This is a competitively awarded, firm fixed price contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,030.64 to AmerisourceBergen Drug Corp for the supply of Cervidil 10 mg vaginal inserts. This firm fixed-price contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive delivery order under DLA's existing pharmaceutical supply framework. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $2,030.64 for Cervidil 10 mg vaginal inserts by the Defense Logistics Agency's Medical Supply Chain. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of August 5, 2025. This delivery order represents a child contract under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, valued at $6,239.40, to AmerisourceBergen Drug Corp for the supply of CERVIDIL 10 MG vaginal inserts. This order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen Drug Corp, a subsidiary of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,437.25 firm fixed-price delivery order is for the supply of Cervidil, a 10 mg vaginal insert product, with a completion date of November 7, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cervidil 10 mg vaginal inserts. The ceiling value of the delivery order is $1,211.20, with a completion date of May 16, 2023. This award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical distributor, to supply CERVIDIL 10 MG vaginal inserts. The delivery order has a ceiling value of $8,673.52 and a period of performance through March 26, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565862431 CERVIDIL 10 MG VAGINAL INSRTS, a specialty pharmaceutical product. The fixed-price contract has a ceiling value of $1,871.82 and an ultimate completion date of September 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAH9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cervidil 10 mg vaginal inserts, a pharmaceutical product used in obstetric care. This firm fixed-price delivery order, valued at $3,384.40, was competitively awarded without set-aside designation and carries an ultimate completion date of July 30, 2025. The contract was awarded on July 29, 2025, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. As a primary pharmaceutical vendor supporting the Defense Health Agency and military healthcare systems, AmerisourceBergen fulfills critical medical supply needs across multiple therapeutic domains through this comprehensive global pharmaceutical support vehicle. The company's federal contracting portfolio demonstrates consistent capability in delivering specialized pharmaceuticals and medical supplies to support military and veteran healthcare programs through competitively awarded contracts with firm fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 7/29/25 |